News
-
Many Neoantigen Candidates Identified by Isolating Circulating Tumor Cells (CTCs) from Blood and Performing Genomic Analysis—Paper Published
-
Notice to Participants Who Took Part in the Feasibility Study of Neoantigen DC Therapy
-
Circulating Tumor Cell–Derived Neoantigen Peptide Study Group Website Now Live
-
Notice of Becoming a Wholly Owned Subsidiary
-
Domestic patent granted
-
A project to promote “custom-made” medical care using genomic information has been launched
-
Joint research agreement concluded with the National Cancer Center Research Institute
-
PCT international application filed
-
Joint research agreement signed with Musashino University
-
Joint research agreement concluded with the National Institute for Materials Science
12



